Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 21;24(35):8717-8726.
doi: 10.1002/chem.201706180. Epub 2018 May 14.

Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods

Affiliations
Review

Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods

Bishnu P Joshi et al. Chemistry. .

Abstract

The accumulation of therapeutic and imaging agents at sites of interest is critical to their efficacy. Similarly, off-target effects (especially toxicity) are a major liability for these entities. For this reason, the use of delivery vehicles to improve the distribution characteristics of bio-active agents has become ubiquitous in the field. However, the majority of traditionally employed, cargo-bearing platforms rely on passive accumulation. Even in cases where "targeting" functionalities are used, the agents must first reach the site in order for the ligand-receptor interaction to occur. The next stage of vehicle development is the use of "recruited" entities, which respond to biological signals produced in the tissues to be targeted, resulting in improved specificities. Recently, many advances have been made in the utilization of cells as delivery agents. They are biocompatible, exhibit excellent circulation lifetimes and tissue penetration capabilities, and respond to chemotactic signals. In this Minireview, we will explore various cell types, modifications, and applications where cell-based delivery agents are used.

Keywords: biological activity; bioorganic chemistry; cancer; drug delivery; nanotechnology.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Cell types employed as delivery vehicles and locations where they are recruited/used to deliver agents to.
Figure 2.
Figure 2.
Non-covalent cellular modifications for cargo delivery. (Above) Red blood cells (red), leukocytes (pink) and stem cells (purple) have been noncovalently modified at the cell surface to display various agent types shown. (Below) Stem cells and leukocytes have the innate ability to internalize cargo shown. Specialized methods must be used for RBCs (not shown) to uptake therapeutic entities.
Figure 3.
Figure 3.
Strategies for covalent cell surface modifications. Click chemistry methods involve coupling of metabolically incorporated azides to phosphines or alkynes for cargo delivery. NHS esters and maleimides can be used for conjugations to amines and thiols, respectively. Biotin can be linked to the cell membrane via several means, and then associate with streptavidin-related proteins linked to chemical moieties.

References

    1. Parveen S, Misra R, Sahoo SK, Nanomed. Nanotechnol. Biol. Med 2012, 8, 147–166. - PubMed
    1. Allen TM, Cullis PR, Adv. Drug Delivery Rev 2013, 65, 36–48. - PubMed
    1. Matsumura Y, Kataoka K, Cancer Sci 2009, 100, 572–579. - PMC - PubMed
    1. Ashley GW, Henise J, Reid R, Santi DV, Proc. Natl. Acad. Sci. USA 2013, 110, 2318–2323. - PMC - PubMed
    1. Brannon-Peppas L, Blanchette JO, Adv. Drug Delivery Rev 2004, 56, 1649–1659. - PubMed

LinkOut - more resources